GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » 5-Year Yield-on-Cost %

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) 5-Year Yield-on-Cost % : 4.40 (As of May. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria 5-Year Yield-on-Cost %?

GlaxoSmithKline Consumer Nigeria's yield on cost for the quarter that ended in Jun. 2023 was 4.40.


The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost % or its related term are showing as below:

NSA:GLAXOSMITH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.19   Med: 6.39   Max: 19.67
Current: 4.4


During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest Yield on Cost was 19.67. The lowest was 1.19. And the median was 6.39.


NSA:GLAXOSMITH's 5-Year Yield-on-Cost % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.125 vs NSA:GLAXOSMITH: 4.40

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost % falls into.



GlaxoSmithKline Consumer Nigeria 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of GlaxoSmithKline Consumer Nigeria is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


GlaxoSmithKline Consumer Nigeria 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines